Genialis
Genialis is a precision oncology company that leverages advanced AI and deep biological expertise to develop clinically actionable RNA biomarkers and therapeutic intelligence solutions. Their proprietary AI Supermodel and diverse global cancer datasets enable accurate prediction of patient responses, mechanism of action elucidation, and patient stratification to enhance clinical trial success and drug development. Genialis offers products like Genialis krasID, ResponderID, and Expressions, serving pharmaceutical and diagnostics partners to reduce clinical trial costs, optimize patient cohorts, and accelerate market entry. The company operates on a SaaS and services business model, emphasizing people-first values and a strong team of PhDs in data science, AI, bioinformatics, and cancer biology, positioning itself as a leader in precision medicine and biomarker discovery.
Genialis
Genialis is a precision oncology company that leverages advanced AI and deep biological expertise to develop clinically actionable RNA biomarkers and therapeutic intelligence solutions. Their proprietary AI Supermodel and diverse global cancer datasets enable accurate prediction of patient responses, mechanism of action elucidation, and patient stratification to enhance clinical trial success and drug development. Genialis offers products like Genialis krasID, ResponderID, and Expressions, serving pharmaceutical and diagnostics partners to reduce clinical trial costs, optimize patient cohorts, and accelerate market entry. The company operates on a SaaS and services business model, emphasizing people-first values and a strong team of PhDs in data science, AI, bioinformatics, and cancer biology, positioning itself as a leader in precision medicine and biomarker discovery.